Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.

Szegedi, István; Orbán-Kálmándi, Rita; Nagy, Attila; Sarkady, Ferenc; Vasas, Nikolett; Sik, Máté; Lánczi, Levente István; Berényi, Ervin; Oláh, László; CriÈan, Alexandra; Csiba, László; Bagoly, Zsuzsa

Szegedi, István; Orbán-Kálmándi, Rita; Nagy, Attila; Sarkady, Ferenc; Vasas, Nikolett; Sik, Máté; Lánczi, Levente István; Berényi, Ervin; Oláh, László; CriÈan, Alexandra; Csiba, László; Bagoly, Zsuzsa.

Afiliação

Szegedi I; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
Orbán-Kálmándi R; Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Nagy A; Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.
Sarkady F; Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Vasas N; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Sik M; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Lánczi LI; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Berényi E; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Oláh L; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
CriÈan A; Department of Neurology, City Hospital of Odorheiu-Secuiesc, Odorheiu Secuiesc, Romania.
Csiba L; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
Bagoly Z; ELKH-DE Cerebrovascular and Neurodegenerative Research Group, Debrecen, Hungary.

PLoS One ; 16(7): e0254253, 2021.

Article em En | MEDLINE | ID: mdl-34234378

Assuntos

Fator XIII/genética; Fibrinolíticos/administração & dosagem; AVC Isquêmico/tratamento farmacológico; AVC Isquêmico/genética; Polimorfismo Genético/genética; Trombose/tratamento farmacológico; Administração Intravenosa; Idoso; Estudos de Casos e Controles; Feminino; Fibrinogênio/genética; Fibrinólise/efeitos dos fármacos; Fibrinólise/genética; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Prospectivos; Terapia Trombolítica/métodos; Trombose/genética; Ativador de Plasminogênio Tecidual/genética; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Trombose / Fator XIII / Fibrinolíticos / AVC Isquêmico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google